Clinical Trial Update: Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

This is a Phase 2 trial comparing docetaxel, carboplatin, and trastuzumab versus vinorelbine and trastuzumab in HER-2 positive metastatic breast cancer. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED